of C. lusitaniae. The mechanism of acquisition is probably indirect contact transmission between patients.
Candida lusitaniae was originally isolated from the intestinal contents of warm-blooded animals (25) . In humans, C. lusitaniae rarely causes opportunistic infections, although 13 cases involving various sites, including the kidneys, peritoneum, and blood stream, have been described (2, 5, 8-10, 12, 18, 23) . This species of Candida is of special interest because of its innate resistance to amphotericin B and its ability to develop resistance to amphotericin during therapy (1, 2, 8, 9, 15) . Little is known about the epidemiology of infection with C. lusitaniae. Studies suggest that broad-spectrum antibiotics and prolonged hospitalization may contribute to both colonization and infection (2, 5, 9, 10, 12, 13, 18) . To evaluate the epidemiology of nosocomial infection, we conducted a prospective study to identify risk factors, patient and hospital reservoirs, and possible mechanisms of transmission.
(This work was presented in part at the 90th Annual Meeting of the American Society for Microbiology, 13 to Control strains of C. lusitaniae were obtained from two patients located in a geographically separate hospital, and C. lusitaniae ATCC 34449 was also used as a control strain. Susceptibility of C. lusitaniae isolates to amphotericin B was evaluated by using previously published methods (6) . Isolates were evaluated for molecular relatedness by using restriction enzyme analysis (REA). These methods have been previously used to evaluate the relatedness of bacteria, viruses, and yeasts (7, 14, 19, 20, 26, 28) . For the isolation of DNA, yeast cells were grown on Sabouraud dextrose agar plates at 30°C for 36 h. The method used to isolate genomic DNA has been previously published (26) . For the electrophoresis of samples, 20 ,ug of DNA was digested with 5 ,ul of the restriction endonucleases EcoRI and MspI (Bethesda Research Laboratories, Gaithersburg, Md.), following the recommendations of the manufacturer. The DNA was run on a 0.7% agarose gel apparatus at 30 V for 16 h. The gel was stained in a solution of 0.5 ,ug of ethidium bromide per ml and then destained in water before being photographed.
During the study period, we monitored 98 patients hospitalized in the BMTU and ICU. Six patients were transferred between the BMTU and the ICU during their hospital stays. Patients were hospitalized in the ICU for a mean of 11.3 days (range, 2 to 43 days) and in the BMTU for a mean of 27.4 days (range, 3 to 73 days). Seven patients were found to harbor C. lusitaniae during their hospital stay. One patient with C. lusitaniae was readmitted; two were transferred between the BMTU and the ICU. The recovery of C. lusitaniae by sample source and as a proportion of total Candida species is shown in Table 1 . The hospital location of patients with C. lusitaniae is shown in Fig. 1 Figure 1 shows the eight strain types from separate patients. Lanes A to F are the strains digested with MspI. Because two groups had three isolates each, EcoRI digestion is shown for these six isolates (lanes I to N). Patients' locations reflecting predominant strain type are shown in Fig. 2 . One strain was shared by five patients and the two environmental isolates. These patients were temporally and geographically related. One patient with this strain was moved between the ICU and the BMTU. One strain type was shared by a patient and control isolate. The isolates from the remaining patient, one control strain, and the ATCC strain were each found to be separate strains having unique restriction fragment length polymorphisms. Evaluation of isolates colonizing different body sites within an individual patient showed that four patients were colonized with the same strains at all sites. In three patients, two different strains of C. lusitaniae were identified in rectal and oropharyngeal cultures. Analysis of 17 isolates recovered from multiple sites in a single patient over a 12-week period showed persistence of the same strain. The restriction fragment length polymorphism pattern remained the same in all isolates and unique to that patient over the 12-week period of this patient's hospitalization. Also, the colonizing urine strain type was identical to the infecting strain type in the patient that developed the urinary tract infection with C. lusitaniae.
Candida lusitaniae is an infrequent opportunistic pathogen but of special interest in view of its ability to develop resistance to amphotericin B (1, 2, 8, 9, 15) . All fatal cases of C. lusitaniae fungemia previously reported have involved resistant isolates (2, 3, 5, 8-10, 12, 13, 15, 16, 18, 21 (17) . There have been occasional reports of Candida species outbreaks with suspected patient-to-patient spread or suspected acquisition from environmental sources (4, 11, 22, 24, 27) . This study demonstrates exogenous acquisition of C. lusitaniae within the hospital environment and traces the route of acquisition. Nosocomial acquisition of C. lusitaniae was shown for five patients who were geographically and temporally associated in a BMTU and an ICU. All patients were cared for by the same unit personnel. We also found that individual patients carried more than one strain type. Patients, however, usually carried the same strains at multiple sites and over time.
The mechanism of acquisition of C. lusitaniae remains uncertain. However, indirect contact transmission via carriage on the hands of hospital personnel is suggested by clustering of patients with identical strains and by the isolation of C. lusitaniae from an environmental surface frequently in contact with hands. The potential hospital reservoirs include colonized patients, hospital personnel, and the inanimate hospital environment. These findings show that nosocomial C. lusitaniae colonization occurred and was the result of exogenous acquisition of strains.
Although the incidence of colonization is low and infection by C. lusitaniae is rare, the isolation of C. lusitaniae from the environment and patients indicates that the potential for spread exists.
